Line 44: | Line 44: | ||
</div> | </div> | ||
<center><img src="https://static.igem.org/mediawiki/2018/7/79/T--Nottingham--logo.png"></center> | <center><img src="https://static.igem.org/mediawiki/2018/7/79/T--Nottingham--logo.png"></center> | ||
+ | </section> | ||
+ | <section> | ||
+ | <center><img src="https://static.igem.org/mediawiki/2018/7/79/T--Nottingham--logo.png" style=" | ||
+ | max-width: 350px; | ||
+ | padding-bottom: 20px; | ||
+ | "></center> | ||
</section> | </section> | ||
<style> | <style> |
Revision as of 21:42, 17 October 2018
Clostridium difficile infection is the most common cause of antibiotic-associated diarrhoea in the Western World and is a big problem in hospitals and care-facilities.
A consequence of antibiotic misuse and the capability of bacteria to readily evolve has allowed antibiotic resistance to become a worldwide major dilemma.
The goal of our project is to engineer a phage which will infect C. difficile and express genetic constructs designed to suppress toxin production.
What is C. difficile infection?
What is the problem?
What are we going to do?